A citation-based method for searching scientific literature


List of co-cited articles
817 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
269
30

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
R Shiang, L M Thompson, Y Z Zhu, D M Church, T J Fielder, M Bocian, S T Winokur, J J Wasmuth. Cell 1994
917
24

Cellular signaling by fibroblast growth factor receptors.
V P Eswarakumar, I Lax, J Schlessinger. Cytokine Growth Factor Rev 2005
22




Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
C Deng, A Wynshaw-Boris, F Zhou, A Kuo, P Leder. Cell 1996
834
17


Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.
Corine G M L'Hôte, Margaret A Knowles. Exp Cell Res 2005
157
15

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
F Rousseau, J Bonaventure, L Legeai-Mallet, A Pelet, J M Rozet, P Maroteaux, M Le Merrer, A Munnich. Nature 1994
649
15


FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Edwin Li, Min You, Kalina Hristova. J Mol Biol 2006
87
16

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
J S Colvin, B A Bohne, G W Harding, D G McEwen, D M Ornitz. Nat Genet 1996
687
14

Physical basis behind achondroplasia, the most common form of human dwarfism.
Lijuan He, William Horton, Kalina Hristova. J Biol Chem 2010
29
48

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
G A Bellus, I McIntosh, E A Smith, A S Aylsworth, I Kaitila, W A Horton, G A Greenhaw, J T Hecht, C A Francomano. Nat Genet 1995
332
13



Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
P L Tavormina, R Shiang, L M Thompson, Y Z Zhu, D J Wilkin, R S Lachman, W R Wilcox, D L Rimoin, D H Cohn, J J Wasmuth. Nat Genet 1995
477
12

Measuring the energetics of membrane protein dimerization in mammalian membranes.
Lirong Chen, Lawrence Novicky, Mikhail Merzlyakov, Tihomir Hristov, Kalina Hristova. J Am Chem Soc 2010
92
13

The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization.
Lirong Chen, Jesse Placone, Lawrence Novicky, Kalina Hristova. Sci Signal 2010
46
26

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.
G A Bellus, E B Spector, P W Speiser, C A Weaver, A T Garber, C R Bryke, J Israel, S S Rosengren, M K Webster, D J Donoghue,[...]. Am J Hum Genet 2000
114
12

FGFR activation in skeletal disorders: too much of a good thing.
M K Webster, D J Donoghue. Trends Genet 1997
259
11

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
Bas W G van Rhijn, Angela A G van Tilborg, Irene Lurkin, Jacky Bonaventure, Annie de Vries, Jean-Paul Thiery, Theodorus H van der Kwast, Ellen C Zwarthoff, Francois Radvanyi. Eur J Hum Genet 2002
119
11

FGFR3-related dwarfism and cell signaling.
Daisuke Harada, Yoshitaka Yamanaka, Koso Ueda, Hiroyuki Tanaka, Yoshiki Seino. J Bone Miner Metab 2009
25
44

Quantitative measurements of protein interactions in a crowded cellular environment.
Edwin Li, Jesse Placone, Mikhail Merzlyakov, Kalina Hristova. Anal Chem 2008
31
35


FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.
Lijuan He, Nadia Shobnam, William C Wimley, Kalina Hristova. J Biol Chem 2011
27
40

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
262
11

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
101
11

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
D Cappellen, C De Oliveira, D Ricol, S de Medina, J Bourdin, X Sastre-Garau, D Chopin, J P Thiery, F Radvanyi. Nat Genet 1999
526
10

Clinical spectrum of fibroblast growth factor receptor mutations.
M R Passos-Bueno, W R Wilcox, E W Jabs, A L Sertié, L G Alonso, H Kitoh. Hum Mutat 1999
221
10


The A391E mutation enhances FGFR3 activation in the absence of ligand.
Fenghao Chen, Catherine Degnin, Melanie Laederich, William A Horton, Kalina Hristova. Biochim Biophys Acta 2011
25
40

Cell signaling by receptor tyrosine kinases.
Mark A Lemmon, Joseph Schlessinger. Cell 2010
10


Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
Jay Y Cho, Changsheng Guo, Monica Torello, Gregory P Lunstrum, Tomoko Iwata, Chuxia Deng, William A Horton. Proc Natl Acad Sci U S A 2004
91
9

Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.
C A Bell, J A Tynan, K C Hart, A N Meyer, S C Robertson, D J Donoghue. Mol Biol Cell 2000
116
9

Structural basis for fibroblast growth factor receptor activation.
Moosa Mohammadi, Shaun K Olsen, Omar A Ibrahimi. Cytokine Growth Factor Rev 2005
504
9


Achondroplasia is defined by recurrent G380R mutations of FGFR3.
G A Bellus, T W Hefferon, R I Ortiz de Luna, J T Hecht, W A Horton, M Machado, I Kaitila, I McIntosh, C A Francomano. Am J Hum Genet 1995
337
9

Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis.
K Peters, D Ornitz, S Werner, L Williams. Dev Biol 1993
409
9

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway.
M Sahni, D C Ambrosetti, A Mansukhani, R Gertner, D Levy, C Basilico. Genes Dev 1999
279
8



Achondroplasia: from genotype to phenotype.
Pascal Richette, Thomas Bardin, Chantal Stheneur. Joint Bone Spine 2008
43
18

Signalling by receptor tyrosine kinases.
W J Fantl, D E Johnson, L T Williams. Annu Rev Biochem 1993
909
8

Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers.
Toon H Evers, Elisabeth M W M van Dongen, Alex C Faesen, E W Meijer, Maarten Merkx. Biochemistry 2006
134
8

Structural basis for FGF receptor dimerization and activation.
A N Plotnikov, J Schlessinger, S R Hubbard, M Mohammadi. Cell 1999
445
8


Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
78
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.